References for the bladder cancer information section

The information in the bladder cancer information section is based on our booklets Understanding non-invasive bladder cancer and Understanding invasive and advanced bladder cancer. These booklets were produced in accordance with the following sources and guidelines.

Understanding non-invasive bladder cancer

• Guidelines on Non-Muscle-Invasive Bladder Cancer (TaT1 and CIS). 2011. European Association of Urology.
• Joint Consensus Statement on the Initial Assessment of Haematuria. 2008. Renal Association and British Association of Urological Surgeons.
• Management of Transitional Cell Cancer of the Bladder. December 2005. Scottish Intercollegiate Guideline Network (SIGN).
• Shelley M, et al. Intravesical chemotherapy for superficial bladder cancer: a systematic review of randomised trials and meta-analysis. Cancer Treatment Review. 2010. 36: 195–205.

Understanding invasive and advanced bladder cancer 

• Bladder cancer: ESMO practice guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 2010. 21 (5): v134–v136.
• European Association of Urology. Guidelines on bladder cancer: muscle-invasive and metastatic. 2011.
• Board of the Faculty of Clinical Oncology. Radiation Dose-Fractionation. Section 4.2 Bladder cancer. London: Royal College of Radiologists. 2006.
• Edge, S, et al. AJCC Cancer Staging Manual. Berlin: Springer, 2010.
• British Association of Urological Surgeons (BAUS) Section of Oncology and
• British Uro-oncology (BUG). Multi-disciplinary team Guidance for Managing Bladder Cancer. 2007.
• National Institute for Health and Clinical Excellence. 2005. NHS guidelines for suspected cancer in adults and children.
• National Institute for Health and Clinical Excellence, 2002. Improving outcomes in urological cancers: the manual.
• National Institute for Health and Clinical Excellence, 2002 Improving outcomes in urological cancers: the research evidence.
• National Institute for Health and Clinical Excellence, 2002. Improving outcomes in urological cancers: guidance for general practitioners and primary care teams.
• Scottish Intercollegiate Guidelines Network (SIGN), 2005. Management of transitional cell carcinoma of the bladder.

Guidelines are constantly being updated and those noted above may have been revised since the booklet was produced. For more information see our general bibliography|.